BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Hepatitis, Kidney, Early pregnancy factor, Cisplatin, rs4950928, ERBB2, Angiogenesis)
Bookmark Forward

QuickView for METTL3 (gene)


Body Atlas

Most Correlated Tissues

  1. Natural killer cell of peripheral blood
  2. T Lymphocyte (regulatory) of peripheral blood
  3. Hematopoietic stem cell of bone marrow
  4. Parotid gland
  5. Granulocyte-macrophage progenitor cell of bone marrow
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Bacterial sepsis of newborn
  2. Chronic fatigue syndrome
  3. Disease due to Arenavirus
  4. Rhinitis
  5. Finding related to pregnancy
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Atractyloside
  2. eburnamonine
  3. Probucol
  4. Cantharidin
  5. Piracetam
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. GIS2
  2. BAR1
  3. SET2
  4. METTL3
  5. EIF4EBP3
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. METTL3's role in cervical cancer development through m6A modification.
  2. m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.
  3. Mettl3-Mediated m6A Methylation Controls Pancreatic Bipotent Progenitor Fate and Islet Formation.
  4. METTL3-mediated m6A modification of SOX4 regulates osteoblast proliferation and differentiation via …
  5. Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study on the Efficacy and Mechanism of METTL3 Peptide Inhibitors in Enhancing Anti-tumor Immune Resp…
  2. Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPI…
  3. Oral Administration of STC-15 in Subjects With Advanced Malignancies
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.